Phenotypic and treatment outcome data on SUNCT and SUNA, including a randomised placebo-controlled trial

Hsing Yu Weng, Anna S. Cohen, Christoph Schankin, Peter J. Goadsby

研究成果: 雜誌貢獻文章

10 引文 斯高帕斯(Scopus)

摘要

Background: Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) and short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA) are two rare headache syndromes classified broadly as Trigeminal Autonomic Cephalalgias (TACs). Methods: Here, 65 SUNCT (37 males) and 37 SUNA (18 males) patients were studied to describe their clinical manifestations and responses to treatment. Results: Pain was almost always unilateral and side-locked. There were three types of attack: Single stabs, stab groups, and a saw-tooth pattern, with some patients experiencing a mixture of two types. As to cranial autonomic symptoms, SUNA patients mainly had lacrimation (41%) and ptosis (40%). Most cases of the two syndromes had attack triggers, and the most common triggers were touching, chewing, or eating for SUNCT, and chewing/eating and touching for SUNA. More than half of each group had a personal or family history of migraine that resulted in more likely photophobia, phonophobia and persistent pain between attacks. For short-term prevention, both syndromes were highly responsive to intravenous lidocaine by infusion; for long-term prevention, lamotrigine and topiramate were effective for SUNCT, and lamotrigine and gabapentin were efficacious in preventing SUNA attacks. A randomized placebo-controlled cross-over trial of topiramate in SUNCT using an N-of-1 design demonstrated it to be an effective treatment in line with clinical experience. Conclusions: SUNCT and SUNA are rare primary headache disorders that are distinct and very often tractable to medical therapy.
原文英語
期刊Cephalalgia
DOIs
出版狀態接受/付印 - 一月 1 2017

ASJC Scopus subject areas

  • Clinical Neurology

指紋 深入研究「Phenotypic and treatment outcome data on SUNCT and SUNA, including a randomised placebo-controlled trial」主題。共同形成了獨特的指紋。

  • 引用此